Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 10:14 am Purchase | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | CVI Investments, Inc. | 200,000 6.200% | 200,000 (New Position) | Filing History |
| 2025-04-09 5:31 pm Unchanged | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-08 8:00 pm Purchase | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | BIGGER CAPITAL FUND L P | 200,000 6.200% | 200,000 (New Position) | Filing History |
| 2025-04-07 4:51 pm Purchase | 2025-04-02 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 200,000 6.210% | 200,000 (New Position) | Filing History |
| 2025-02-10 6:58 pm Unchanged | 2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 76,598 4.990% | 0 (Unchanged) | Filing History |
| 2025-02-10 4:24 pm Purchase | 2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 76,598 4.990% | 76,598 (New Position) | Filing History |
| 2024-11-14 3:45 pm Purchase | 2024-09-30 | 13G | Aptevo Therapeutics Inc. APVO | ARMISTICE CAPITAL LLC | 22,128 4.990% | 22,128 (New Position) | Filing History |
| 2024-11-08 2:57 pm Purchase | 2024-09-30 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 25,285 6.960% | 25,285 (New Position) | Filing History |
| 2024-02-14 3:24 pm Purchase | 2023-12-31 | 13G | Aptevo Therapeutics Inc. APVO | ARMISTICE CAPITAL LLC | 1,063 9.990% | 1,063 (New Position) | Filing History |
| 2023-02-14 10:15 am Sale | 2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RTW INVESTMENTS LP | 0 0.000% | -177 (Position Closed) | Filing History |
| 2022-02-10 3:18 pm Sale | 2021-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RENAISSANCE TECHNOLOGIES LLC | 42 1.400% | -114 (-73.00%) | Filing History |
| 2021-11-26 1:00 pm Sale | 2021-11-23 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 0 0.000% | -566 (Position Closed) | Filing History |
| 2021-11-22 5:28 pm Sale | 2021-11-18 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 566 18.800% | -515 (-47.65%) | Filing History |
| 2021-06-21 09:00 am Unchanged | 2021-06-21 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 1,081 39.600% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:13 pm Sale | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Point72 Asset Management, L.P. | 0 0.000% | -178 (Position Closed) | Filing History |
| 2021-02-16 2:51 pm Unchanged | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | ARMISTICE CAPITAL LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-12 4:56 pm Purchase | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Stonepine Capital Management LLC | 11 0.400% | 11 (New Position) | Filing History |
| 2021-02-12 09:25 am Sale | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RTW INVESTMENTS LP | 177 6.960% | -1 (-0.61%) | Filing History |
| 2021-02-10 9:17 pm Purchase | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RENAISSANCE TECHNOLOGIES LLC | 156 5.810% | 156 (New Position) | Filing History |
| 2021-02-09 08:30 am Unchanged | 2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 1,081 40.200% | 0 (Unchanged) | Filing History |